Venture Portfolio - Mimetas


Key figures

  • 2013
    Creation Date
  • 92
    Number of Employees
  • 2020
    Investment Date
  • OMX
    Fund Name

Company presentation

Mimetas is the market leader in Organ-on-a-Chip technology, based in The Netherlands, Maryland, US, and Tokyo, Japan.

Their flagship product, the OrganoPlate®, supports 3D cell culture under continuous perfusion. The OrganoPlate allows permeability, transport, migration/invasion, and co-culture assays without the use of filter membranes.

Mimetas works with the majority of pharma and biotech companies around the world. Their extensive R&D team has developed a broad spectrum of models and assays to advance drug development.


J.H. Oortweg 19 - 2333 Leiden - THE NETHERLANDS

Key contacts